Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of WellCare Health Plans were looking reinvigorated today, climbing as much as 12% after reporting earnings this morning.
So what: Sales hit $1.99 billion for the quarter, ahead of estimates of $1.89 billion, and adjusted earnings of $1.32 beat the Street by $0.07. Per-share profits were still down considerably from a year ago, when they hit $1.96, because of rising costs. The health insurer was also boosted by a 7% premium increase for its Medicaid program in Kentucky that went into effect Jan. 1, and a 3% increase scheduled for July 1. Because of that increase, WellCare increased its 2013 revenue outlook to $8.7 billion to $8.8 billion. Analysts had expected $8.5 billion.
Now what: Its EPS forecast for 2013 was still below estimates, however, as the company struggles to deal with increasing expenses. CEO Alec Cunningham touted his company's diversified portfolio, saying it began 2013 with a number of promising growth opportunities in attractive markets, but that WellCare's rising costs underscore the risks of investing in health care insurers, especially with the uncertainty from the Affordable Care Act. I'd be more comfortable investing in WellCare if profits were growing along with revenues.
Is this insurer right for your portfolio?
When President Obama was reelected, shares of UnitedHealth and other health insurers fell immediately. Is Obamacare a death knell for health insurers, or is the market missing out on some of the opportunities the law presents? In this brand new premium report on UnitedHealth, we take the long term view, honing in on prospects for UnitedHealth in a post-Obamacare world. The report also comes with a full year of analyst updates to keep you covered as key news develops, so don't miss out -- simply click here now to claim your copy today.
The article Why WellCare Shares Jumped originally appeared on Fool.com.
Fool contributor Jeremy Bowman has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.